VIVAX | WLCVX | VIVAX / WLCVX | |
Total Expense Ratio | 0.17 | 1.00 | 17% |
Annual Report Gross Expense Ratio | 0.17 | 1.03 | 17% |
Fund Existence | 33 years | 29 years | - |
Gain YTD | 9.738 | 10.776 | 90% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 3000 | 250000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 208B | 168M | 123,810% |
Annual Yield % from dividends | 1.97 | 1.20 | 165% |
Returns for 1 year | 4.63 | 0.71 | 651% |
Returns for 3 years | 42.99 | 29.52 | 146% |
Returns for 5 years | 71.78 | 40.85 | 176% |
Returns for 10 years | 129.45 | 29.88 | 433% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
CEIIX | 13.50 | 0.21 | +1.58% |
Manning & Napier Callodine Equity Inc I | |||
MDBAX | 20.13 | 0.13 | +0.65% |
BlackRock Large Cap Focus Value Inv A | |||
RYHIX | 132.85 | 0.50 | +0.38% |
Rydex Health Care Inv | |||
BGAIX | 47.58 | 0.03 | +0.06% |
Baron Global Opportunity Institutional | |||
LMGFX | 76.41 | -0.09 | -0.12% |
ClearBridge International Growth FI |